Kava vs. Kratom
10 November 2026
Kava and kratom are two unrelated plants from different parts of the world. Kava (Piper methysticum) is a root from the South Pacific. Kratom (Mitragyna speciosa) is a leaf from a tree in Southeast Asia. They have different chemistry, different regulatory histories and different legal status in the US, and they are often confused because both appear in the same botanical and specialty-shop conversations.
This guide compares them on the points that matter to a buyer of botanical raw materials: where each plant comes from, what compounds it contains, how US agencies treat it, and what quality documentation to look for. Our kratom powder is sold for soap making and as an accessory-category item. It is not sold for human consumption, and nothing here should be read as a use recommendation.
TL;DR
- Kava is a pepper-family root from the South Pacific. Kratom is a leaf from a tree native to Southeast Asia.
- Kava’s active compounds are kavalactones. Kratom contains dozens of alkaloids, with mitragynine the most abundant.
- In the US, kava is not a controlled substance. Kratom is not federally scheduled either, but it is banned in a handful of states and the FDA has not approved it for medicinal use.
- For any botanical, a batch-level independent lab report and a traceable grower network are the best signs of quality.
- Our Maeng Da powders in Red, Green, White and Yellow start from €14.90, and every batch carries independent lab results.
Table of Contents
- Two plants, two origins
- Chemistry: kavalactones versus alkaloids
- How the plants are described by health bodies
- How the US treats each plant
- Safety information worth knowing
- What to look for in any botanical supplier
- Our point of view
- Choosing a Maeng Da powder from Kratomvia
- FAQ
- Sources
Two plants, two origins
Kava is native to the South Pacific and belongs to the pepper family, according to the National Center for Complementary and Integrative Health (NCCIH). The part used is the root, which has a long cultural history across Pacific island communities.
Kratom comes from the leaves of Mitragyna speciosa, a tree native to Southeast Asia, as Pharmacy Times describes it. The tree belongs to the coffee family, not the pepper family, which is the first clue that the two have little in common botanically. If you want the basics on the plant itself, see our guide to what kratom is.
| Kava | Kratom | |
|---|---|---|
| Botanical name | Piper methysticum | Mitragyna speciosa |
| Plant family | Pepper | Coffee |
| Native region | South Pacific | Southeast Asia |
| Part of plant | Root | Leaf |
| Main compound class | Kavalactones | Alkaloids (mitragynine most abundant) |
Chemistry: kavalactones versus alkaloids
The most important difference between the two is chemical, and it is the reason health agencies treat them as separate subjects.
Kava: kavalactones
The DEA’s Diversion Control Division notes that kava’s kavalactones work by enhancing GABA signaling in the brain. Cleveland Clinic adds that kava has 15 identified active ingredients, all known to be psychoactive. GABA is the brain’s main inhibitory messenger system.
Kratom: mitragynine and 7-hydroxymitragynine
Kratom extracts contain at least 54 alkaloids, and mitragynine is the most predominant. A second alkaloid, 7-hydroxymitragynine (7-OH), is present in much smaller amounts. According to Nebraska Medicine, mitragynine is more abundant, while 7-OH acts more strongly and more specifically like an opioid.
The mechanism is where the two plants part ways most clearly. A professional review from Kava Review points out that kavalactones are largely GABA-system modulators, while kratom’s alkaloids act at mu-opioid receptors, which the FDA identifies as the same receptors targeted by opioid drugs. That is why searches such as “is kratom an opioid?” come up so often: kratom is not an opioid drug, but several of its alkaloids interact with opioid receptors. Our own kratom alkaloids guide goes through mitragynine and 7-OH in more detail.
Why alkaloid content varies
Kratom leaf is a natural material, and alkaloid ratios shift with tree age, growing conditions, leaf stage and processing. A 2020 metabolomics study summarized by Pharmacy Times found that speciofoline has no appreciable affinity for human opioid receptors, and researchers suspect that differing concentrations of mitragynine and speciofoline contribute to the variety of reported potency. For a buyer, the practical point is simple: two batches labeled with the same name can differ, which is why a batch-specific lab report matters more than a product name.
How the plants are described by health bodies
Public health sources describe the two plants in very different terms, and the contrast is useful when you are trying to keep them apart.
- Kava. The NCCIH describes kava as typically calming and relaxing. The DEA characterizes its psychoactive effects as generally mild. The Australian Better Health Channel classes it as a central nervous system depressant.
- Kratom. The same NCCIH page describes kratom as behaving differently depending on the amount: low doses are associated with energy and alertness, higher doses with sedation and a greater risk of dependence.
These are descriptions of the plants in the scientific and regulatory literature. We do not sell either one as a product for ingestion, and we do not make claims about personal effects. The distinction between the two plants is also why the comparison articles ranking for this keyword tend to conclude that they are not interchangeable.
How the US treats each plant
Legal status is the part of this comparison that changes most often, so treat the summary below as a map and confirm current rules with your state and the FDA before you buy or resell either botanical.
Kava
Kava is not a controlled substance, and the DEA’s drug information sheet is the federal document that confirms this. The FDA, in its 2020 Scientific Memorandum, concluded that kava is an unapproved food additive when used in conventional foods and that there is no basis to consider it generally recognized as safe as a food ingredient.
Kratom
Kratom is not classified as a controlled substance under the Controlled Substances Act, and the FDA has not approved it for medicinal use. State rules differ: according to Kava Review, kratom is banned in roughly half a dozen states, including Alabama, Arkansas, Indiana, Vermont and Wisconsin, and the FDA recommended on July 29, 2025 that concentrated 7-OH products be scheduled. Local ordinances can add further limits.
Outside the US
Because our store serves customers in Europe and the UK as well, the international picture is worth knowing. Kava Review’s legality overview reports that Germany’s kava ban was lifted by court order in June 2014, that the UK ban largely persists, and that Poland has an outright ban. The University of Florida’s Center for Natural Products notes that kava was barred from clinical use in Europe from 2001 to 2014 over liver concerns. Kratom rules vary by country as well; in Sweden, for example, only mitragynine is classified, not the plant material itself.
| Topic | Kava (US) | Kratom (US) |
|---|---|---|
| Federal scheduling | None | None |
| State bans | None reported | Several states |
| FDA position | Unapproved food additive in conventional foods | Not approved for medicinal use |
| Import notes | No import alerts reported | Standing FDA import alerts |
Safety information worth knowing
Safety facts belong in any honest comparison, so here they are in brief. They are drawn from public health agencies and concern the plants in general, not our products.
- The NCCIH reports that various kava products have been linked to rare cases of liver injury, some serious, and advises against combining kava with other sedating substances such as alcohol or benzodiazepines.
- A CDC report published in 2026 found that kava poison center exposures rose between 2011 and 2025, and that kratom was involved in 30% of 2025 kava reports. The two plants are frequently found together in the same reports, which is another reason to keep them distinct.
- Pharmacy Times notes that kratom has been linked with inhibition of the CYP3A4 and CYP2D6 enzyme pathways, which matters because many medications are processed through them. Anyone taking medication should speak with a pharmacist or physician before using any botanical.
- Pregnant or breastfeeding readers should speak with their clinician, since the NCCIH flags special risks for kava in pregnancy and breastfeeding.
For more on how we think about product safety, see our pieces on kratom side effects and lab testing and why a batch CoA matters for Salmonella screening.
What to look for in any botanical supplier
Whether the material is kava root or kratom leaf, the same quality questions apply. A buyer, and especially a reseller, should ask:
- Is there an independent lab report for the specific batch? A report for a different batch, or a generic statement of purity, does not tell you what is in the bag you receive.
- Can the batch be traced? A batch number that ties a product to its report and its growers is the minimum.
- Is the origin specific? Kava comes from the Pacific and kratom from Southeast Asia. A seller who names the region and describes its grower relationships is giving you something checkable.
- Is the packaging clear and the shipping reliable? For orders in Europe and the UK, discreet, plain packaging is standard in our shop.
These are the standards we hold ourselves to. We source kratom from a small, known network of growers in Southeast Asia, every batch is independently lab-tested and traceable by batch number, and batch lab results are publicly available.
Our point of view
Comparisons between kava and kratom usually blur two very different plants into one category. We think buyers are better served by treating them separately: different botany, different chemistry, different rules.
Our work is kratom, and we approach it as a raw botanical material. That means knowing the growers, testing every batch with an independent laboratory, publishing the results and labeling each batch so it can be traced. We believe transparency is what separates a dependable supplier from an anonymous bulk source.
We also believe the clearest way to describe our powders is by what we can document: the strain, the region, the batch number and the lab report. Our Maeng Da powders in Red, Green, White and Yellow are sold for soap making and as accessory-category items, and we ship them in plain, unmarked packaging.
Kratomvia
Choosing a Maeng Da powder from Kratomvia
If you are comparing botanical materials for soap making, our Maeng Da range comes in four colors, each from €14.90. Every batch is independently lab-tested and traceable, with results available publicly, and orders ship discreetly across Europe and the UK.
You can browse by color: Red kratom, Green kratom, White kratom or Yellow kratom. Retailers and resellers can ask us about wholesale bulk orders.
FAQ
Is kratom an opioid?
No, kratom is not an opioid drug, and it is not federally scheduled. However, the FDA notes that kratom’s alkaloids bind to mu-opioid receptors, the same receptors opioid drugs target. A 2020 FDA report predicted that 22 of 25 studied kratom compounds bind to these receptors.
Is 7-OH stronger than kratom leaf?
In laboratory terms, yes. 7-hydroxymitragynine is a minor alkaloid, but Nebraska Medicine explains that it acts more strongly like an opioid than mitragynine does. The FDA recommended in July 2025 that concentrated 7-OH products be scheduled, which is a separate matter from the leaf powder.
Is kava legal in the United States?
Kava is legal in all 50 states and is not a controlled substance, according to the DEA’s kava information sheet. The FDA still treats it as an unapproved food additive in conventional foods and beverages. Rules are different in other countries, so check local law before importing.
Are kava and kratom related plants?
No. Kava is a root from a pepper-family plant native to the South Pacific, while kratom is a leaf from a tree native to Southeast Asia. Their active compounds and their regulatory treatment also differ.
How can I tell whether a kratom batch has been tested?
Look for a batch-specific independent lab report tied to a batch number printed on the product. At Kratomvia, batch results are publicly available and each batch is traceable.
Sources
- Kava: Usefulness and Safety, NCCIH
- Understanding Kratom: Pharmacology, Safety, and Regulation, Pharmacy Times
- Are “natural” kratom and kava products safe?, Nebraska Medicine
- Kava vs Kratom: Mechanisms, Dependence and Legality Compared, Kava Review
- Is Kava Legal? US States, International and Travel Rules, Kava Review
- KAVA drug information sheet, DEA Diversion Control Division
- Kava: Benefits, Risks and Usage, Cleveland Clinic
- Kava | Better Health Channel
- Scientific Memorandum: Kava, FDA
- Ethnobotanicals and Functional Foods, University of Florida Center for Natural Products
- Increase in Poison Center Reports Linked to Kava, CDC MMWR
- Drug testing for mitragynine and kratom: Analytical challenges, PMC
- Is Feel Free Drink Safe? Kratom, Kava, and Addiction Risks
Recommended
- What Is Kratom?
- Kratom Capsules vs Powder
- Kratom Strains Explained: Red, White & Green
- Kratom Side Effects: What Evidence Supports, What Doesn’t
Disclaimer: This blog is intended for educational and informational purposes only. The content provided is not intended to promote, recommend, or suggest human consumption of kratom or any other product. Our products are sold exclusively for their intended purposes as described on our website. This information should not be interpreted as medical advice, and we encourage readers to consult qualified professionals for any health-related questions.
